Clinical Trial Detail

NCT ID NCT03138070
Title A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lawson Health Research Institute
Indications

head and neck squamous cell carcinoma

Therapies

Alpelisib

Age Groups: senior adult

No variant requirements are available.